| Noor Q Omar, DMD | |
|
10 Avalon Dr, Peabody, MA 01960-1506 | |
| (347) 985-4517 | |
| Not Available |
| Full Name | Noor Q Omar |
|---|---|
| Gender | Female |
| Speciality | Dentist |
| Location | 10 Avalon Dr, Peabody, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205427291 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | DN1858815 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Noor Q Omar, DMD 10 Avalon Dr, Peabody, MA 01960-1506 Ph: (347) 985-4517 | Noor Q Omar, DMD 10 Avalon Dr, Peabody, MA 01960-1506 Ph: (347) 985-4517 |
News Archive
The link between influenza and serious heart conditions just grew stronger. A CDC study looking at more than 80,000 adult patients hospitalized with flu over eight seasons found that sudden, serious heart complications were common, occurring in 12% of patients, or 1 in 8.
The Center for Global Health Policy's "Science Speaks" blog profiles Sens. Barbara Mikulski (D-Md.), Patty Murray (D-Wash.), and Richard Shelby (R-Ala.), discusses their different committee appointments, and examines their support for global health initiatives.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
K2M, Inc., a spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration to market its new CHESAPEAKE™ Anterior-Lumbar Stabilization System, a unique interbody device designed for stabilization of the spine through an anterior approach. The system provides screw fixation through K2M's revolutionary tifix® Locking Technology, whereby each screw head forms an autogenic lock to the implant upon insertion.
Metamark Genetics, Inc., a molecular diagnostics company addressing a major challenge in cancer medicine, has completed a $22 million Series B financing. Metamark's Prognosis Determinants platform has illuminated the genetic drivers governing the lethal metastatic progression of major cancers and is now focused on pivotal translational and commercialization efforts to bring these breakthrough discoveries to cancer patients worldwide.
› Verified 9 days ago
Federico Fabian Lago, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1 Roosevelt Ave, Peabody, MA 01960 Phone: 978-535-2500 | |
Dr. Peter N Hjorth, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 6 Essex Center Dr, Unit #210, Peabody, MA 01960 Phone: 978-531-3010 Fax: 978-977-9828 | |
Dr. Micheline D. Moini, DMD Dentist Medicare: Medicare Enrolled Practice Location: 215 Newbury St Ste 201, Peabody, MA 01960 Phone: 978-224-8895 | |
Dr. Divi Mittal, Dentist Medicare: Medicare Enrolled Practice Location: 1 Main St, Peabody, MA 01960 Phone: 978-238-0309 | |
Paul Talkov, DMD Dentist Medicare: Medicare Enrolled Practice Location: 6 Essex Center Dr, 110, Peabody, MA 01960 Phone: 978-532-0500 Fax: 978-977-3458 | |
Dr. Peter A Morgan, DMD,MSCD Dentist Medicare: Medicare Enrolled Practice Location: 6 Essex Center Dr, 110, Peabody, MA 01960 Phone: 978-532-0500 Fax: 978-977-3458 | |
Dr. Jennifer Lee, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 215 Newbury St, Suite 201, Peabody, MA 01960 Phone: 978-535-3800 Fax: 978-535-1718 |